A carregar...
Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals
Meso-tetra-hydroxyphenyl-chlorin (mTHPC, Foscan®), a promising photosensitizer for photodynamic therapy (PDT), is approved in Europe for the palliative treatment of head and neck cancer. Based on work in mice that investigated optimal tumor accumulation, clinical protocols with Foscan® typically emp...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Association of Physicists in Medicine
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2562246/ https://ncbi.nlm.nih.gov/pubmed/18777912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1118/1.2952360 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|